COVID-19

Microscopic view of the COVID-19 virus

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will provide solutions to the COVID-19 pandemic.

NIBIB is overseeing the Rapid Acceleration of Diagnostic Technologies (RADx Tech) program, a $500 million effort to significantly increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID-19. In addition to this major effort, NIBIB is supporting several areas of technology development outlined in three Notices of Special Interest (NOSIs).

Computer keyboard with a key called apply now

RADx Tech Solicitation

NOSI for Current Grantees

NOSI for SBIR/STTR Applicants

NOSI for all Applicants

RADx UP NOSIs for Current Grantees:
NOT-OD-20-119
NOT-OD-20-120
NOT-OD-20-121

RADx UP RFA - Data Center:
RFA-OD-20-013

Summary data on proposals submitted to the RADx Tech initiative. Data is updated weekly.

RADx Tech FAQs

NOSI FAQs for Researchers/Applicants

NIBIB’s Dr. Kaitlyn Sadtler is a study lead and Principal Investigator working with NIH colleagues to test people who were infected with SARS-CoV-2 and developed antibodies but did not develop symptoms. Read more about the study.

RADx Tech aims to bring accurate and easy-to-use COVID diagnostic tests to all Americans. NIBIB’s Point of Care Technologies Research Network, or POCTRN is one of the tools in NIH’s plan to accomplish this goal.

Transcripts for the video can be found on YouTube.